Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, April 18, 2024 · 704,836,118 Articles · 3+ Million Readers

Contact Lenses Market Provides Key Clinical Trial Data of Ongoing Trials Specific to Pipeline Products

Orbis Research

Orbis Research

Orbisreserach.Com adds “Contact Lenses-Medical Devices Pipeline Assessment, 2017” To Its Research Database

DALLAS, TEXAS, UNITED STATES, July 27, 2017 /EINPresswire.com/ -- GlobalData's Medical Devices sector report, “Contact Lenses - Medical Devices Pipeline Assessment, 2017" provides an overview of Contact Lenses currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Contact Lenses pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/364265

Companies Mentioned:
Aeon Astron Corporation
Alcon Laboratories Inc
Apeliotus Ophthalmics
Auburn University
Axcelon Biopolymers Corp.
Bar-Ilan University
Bausch & Lomb Inc
Children's Hospital Boston
CooperVision Inc
EP Global Communications, Inc.
Euclid Systems Corp
e-Vision Medical Devices, Inc.
Eyenovations
EyeYon Medical
Imperial College London
Johnson & Johnson Vision Care Inc
Massachusetts Eye and Ear Infirmary
Novartis AG
Ocular Dynamics, LLC
Ocutec Ltd
Presbia Plc
RetMap Inc
Stanford University
SynergEyes Inc
The Hong Kong University of Science and Technology
The University of New South Wales
UltraVision CLPL
University of California San Diego
University of Florida
University of Valencia
University of Washington
Valeant Pharmaceuticals International Inc
Visioneering Technologies Inc
VISTAKON Pharmaceuticals LLC
Yolia Health

Scope
- Extensive coverage of the Contact Lenses under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Buy a report @ http://www.orbisresearch.com/contact/purchase/364265

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Contact Lenses under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

List Of Tables:

1.1 List of Tables
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 8
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment 9
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory 10
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path 11
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials 13
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development 15
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status 16
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description 16
Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
Table 13: Peripheral Embolization Device - Product Status 17
Table 14: Peripheral Embolization Device - Product Description 17
Table 15: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 16: EkoSonic Endovascular System - Product Status 18
Table 17: EkoSonic Endovascular System - Product Description 19
Table 18: BTG Plc - Ongoing Clinical Trials Overview 20
Table 19: EkoSonic Endovascular System - Submassive Pulmonary Embolism Experience with EKOS 21
Table 20: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 21: EmboPRO EPD - Product Status 22
Table 22: EmboPRO EPD - Product Description 22
Table 23: CardioGard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 24: CardioGard 22 French Aortic Cannula - Product Status 23
Table 25: CardioGard 22 French Aortic Cannula - Product Description 23
Table 26: CardioGard Ltd. - Ongoing Clinical Trials Overview 24
Table 27: CardioGard 22 French Aortic Cannula - A Study to Collect Additional Information Related to the Performance of the CARDIOGARD Cannula 25
Table 28: EMBA Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 26
Table 29: Hourglass Peripheral Embolization Plug - Product Status 26
Table 30: Hourglass Peripheral Embolization Plug - Product Description 26
Table 31: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 32: Emboliner - Product Status 27
Table 33: Emboliner - Product Description 27
Table 34: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
Table 35: Next Generation Embolic Protection Device - Product Status 28
Table 36: Next Generation Embolic Protection Device - Product Description 28
Table 37: Inari Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 38: FlowTriever System - Pulmonary Embolism - Product Status 29
Table 39: FlowTriever System - Pulmonary Embolism - Product Description 29
Table 40: Inari Medical, Inc. - Ongoing Clinical Trials Overview 30
Table 41: FlowTriever System - Pulmonary Embolism - FlowTriever Pulmonary Embolectomy Clinical Study 31
Table 42: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: EMBLOK Embolic Protection System - Product Status 32
Table 44: EMBLOK Embolic Protection System - Product Description 32
Table 45: Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview 33
Table 46: EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR) 34
Table 47: EMBLOK Embolic Protection System - Safety and Efficacy of EMBLOK Embolic Protection System in Patients with Severe Aortic Stenosis 34
Table 48: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 49: Permanently Implantable Embolic Balloon - Product Status 35
Table 50: Permanently Implantable Embolic Balloon - Product Description 35
Table 51: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 52: TriGuard Cerebral Protection Device - Product Status 36
Table 53: TriGuard Cerebral Protection Device - Product Description 36
Table 54: Keystone Heart Ltd - Ongoing Clinical Trials Overview 37
Table 55: TriGuard Cerebral Protection Device - A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation 38
Table 56: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 57: SilverHawk With SpiderFX Embolic Protection Device - Product Status 39
Table 58: SilverHawk With SpiderFX Embolic Protection Device - Product Description 39
Table 59: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Table 60: Blockstent Microcatheter - Product Status 40
Table 61: Blockstent Microcatheter - Product Description 40
Table 62: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 63: Aortic Embolic Protection Device - Product Status 41
Table 64: Aortic Embolic Protection Device - Product Description 41
Table 65: Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 66: Protection Collar - Product Status 42
Table 67: Protection Collar - Product Description 42
Table 68: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 69: Peripheral Vascular Embolization System - Product Status 43
Table 70: Peripheral Vascular Embolization System - Product Description 43
Table 71: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 44
Table 72: Transcatheter Device - Atherosclerotic Plaque - Product Status 44
Table 73: Transcatheter Device - Atherosclerotic Plaque - Product Description 44
Table 74: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45
Table 75: Embolic Protection Device - Product Status 45
Table 76: Embolic Protection Device - Product Description 45
Table 77: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 46
Table 78: Minimally Invasive Thrombectomy Device - Product Status 46
Table 79: Minimally Invasive Thrombectomy Device - Product Description 46
Table 80: Glossary 114

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Orbis Research
+1 (214) 884-6817
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release